Clinical Trial Update: Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin

View source ↗

Summary

A completed clinical trial evaluated risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in patients treated with rectal indometha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Healthy | Status: COMPLETED